Somatostatin Analog Treatment of Acromegaly Before Pituitary Surgery : Comparison With Neurosurgery Alone
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the interest of a six month pre-operative treatment with
a long-acting somatostatin analog (Sandostatin LP) versus surgery alone in patients with a
pituitary adenoma responsible for acromegaly.